US 9974868
Octapod iron oxide nanoparticles as high performance T2 contrast agents for magnetic resonance imaging
granted A61KA61K49/06A61K49/08
Quick answer
US patent 9974868 (Octapod iron oxide nanoparticles as high performance T2 contrast agents for magnetic resonance imaging) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K49/06, A61K49/08, A61K49/1818, A61K49/1833